Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NASPE’s Name, HQ Change To Reflect Expanded Reach Of Advocacy Group

This article was originally published in The Gray Sheet

Executive Summary

The Heart Rhythm Society's autumn move to Washington, D.C. will enhance ongoing efforts to expand Medicare reimbursement for implantable cardioverter defibrillators, according to the society

You may also be interested in...



LVEF Levels To Be Tracked In Brave New World Of ICD Access? HRF Hopes So

The Heart Rhythm Foundation will distribute a sudden cardiac death "risk-assessment tool" to physicians and the broader public to raise SCD awareness and prompt at-risk patients to consider ICD therapy

LVEF Levels To Be Tracked In Brave New World Of ICD Access? HRF Hopes So

The Heart Rhythm Foundation will distribute a sudden cardiac death "risk-assessment tool" to physicians and the broader public to raise SCD awareness and prompt at-risk patients to consider ICD therapy

CRT/ICD Implantation Guidelines Released For Docs With Pacer Experience

The Heart Rhythm Society's new guidelines for non-electrophysiologist cardiologists who implant defibrillators and cardiac resynchronization therapy (CRT) systems will help industry prepare for an anticipated surge in demand from heart failure patients, HRS says

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020323

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel